CDKN2A and melanoma: Although families identified with CDKN2A mutations display an average disease penetrance of 30% by 50 years of age and 67% by age 80, studies have shown that melanoma risk is greatly influenced by the year an individual is born, levels of sun exposure, and other modifier genes.